3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

AIDS expert reports progress toward HIV vaccine

AIDS/HIVDec 01, 05

A scientist who helped to discover HIV said he has made progress toward producing an AIDS vaccine and hopes to launch a clinical trial in about a year.

Dr. Robert Gallo, the director of the University of Maryland’s Institute for Human Virology, said the results of animal studies are encouraging.

“I think we’ve made some advances in making antibodies that will react with the variety of strains of HIV,” he told Reuters, referring to the virus that causes AIDS.

Scientists believe a vaccine is the best hope for ending the global AIDS pandemic that has killed about 3.1 million people this year. But defeating the virus has proved more difficult than researchers had expected.

Gallo, in Israel to accept an award from Bar-Ilan University in advance of World AIDS day on Thursday, said it is still too early to say when a vaccine could be produced for humans.

Researchers believe an effective AIDS vaccine is still many years away.

“We have had some interesting results in the monkeys that show we can make an immune response,” Gallo said, noting potential progress on overcoming the problem of mutation of the virus.

But the antibodies produced in his experiments lasted only up to four months, which is far less than needed for an effective vaccine.

“We are making progress with a preventive vaccine, but we are not there yet,” added Gallo, who discovered the AIDS virus with France’s Luc Montagnier.

Earlier this week Europe’s biggest drug maker GlaxoSmithKline Plc announced a plan to develop an experimental AIDS vaccine along with France’s Institut Pasteur.

They intend to make the vaccine by fusing genes from HIV on to an existing vaccine for measles.

More than 30 AIDS vaccine trials in humans are ongoing but no one can predict if any will be effective against the virus that infected nearly 5 million people in 2005.

Antiretroviral drugs have prolonged lives of people with HIV/AIDS but public health experts say preventing the spread of virus, by using condoms, abstinence and needle-exchange programs, is also essential for halting the epidemic.

The number of people living with HIV/AIDS hit a record high of 40.3 million this year, according to the latest figures from the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  Cell-associated HIV mucosal transmission: The neglected pathway
  Offering option of initial HIV care at home increases use of ART
  HIV-1 movement across genital tract cells surprisingly enhanced by usurping antibody response
  Indonesia probes Bali tattoo HIV infection report
  Obama raises U.S. goal on fighting AIDS
  New device to test blood can spot cancer cells, HIV on the fly
  Rare HIV-positive individuals shed light on how body could effectively handle infection
  New research examines how HIV infections occur on the molecular level
  An answer to a longstanding question: How HIV infection kills T cells
  Researchers say uncover HIV, insulin resistance link
  Beatrice Hahn and George Shaw, Pioneers in HIV Research, to Join Penn Medicine

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site